Presentation is loading. Please wait.

Presentation is loading. Please wait.

Health-Related Quality of Life of Patients With Multiple Myeloma Treated in Routine Clinical Practice in France  Nicolas Despiégel, Chantal Touboul, Alain.

Published byBeatrix Hutchinson Modified over 6 years ago

Similar presentations

Presentation on theme: "Health-Related Quality of Life of Patients With Multiple Myeloma Treated in Routine Clinical Practice in France  Nicolas Despiégel, Chantal Touboul, Alain."— Presentation transcript:

1 Health-Related Quality of Life of Patients With Multiple Myeloma Treated in Routine Clinical Practice in France  Nicolas Despiégel, Chantal Touboul, Alain Flinois, Grèce Saba, Florence Suzan, Sebastian Gonzalez-McQuire, Franck Bonnetain  Clinical Lymphoma, Myeloma and Leukemia  Volume 19, Issue 1, Pages e13-e28 (January 2019) DOI: /j.clml Copyright © 2018 The Authors Terms and Conditions

2 Figure 1 EORTC QLQ-C30 Global Health Status Scores. Data Presented are Means, First Quartiles, Third Quartiles, and Minimums and Maximums. Open Circles Denote Extreme Values. Higher Scores for EORTC QLQ-C30 Global Health Status Score Indicated Higher Quality of Life. Excluding Supportive Care, Effect of Line on QLQ-C30 Global Health Status Score Was P = by ANOVA Abbreviations: EORTC = European Organization for Research and Treatment of Cancer; QLQ-C30 = Core Quality of Life questionnaire. Clinical Lymphoma, Myeloma and Leukemia  , e13-e28DOI: ( /j.clml ) Copyright © 2018 The Authors Terms and Conditions

3 Figure 2 EORTC QLQ-MY20 Status Scores by Domain. (A) Future Perspectives, (B) Body Image, (C) Disease Symptoms, and (D) Side Effects of Treatment. Data Presented are Means, First Quartiles, Third Quartiles, and Minimums and Maximums. Open Circles Denote Extreme Values. Higher Scores for Future Perspectives and Body Image Indicate Higher HRQoL; Lower Scores for Disease Symptoms and Side Effects of Treatment Indicate Better HRQoL Abbreviations: EORTC = European Organization for Research and Treatment of Cancer; HRQoL = health-related quality of life; QLQ-MY20 = Quality of Life Multiple Myeloma module. Clinical Lymphoma, Myeloma and Leukemia  , e13-e28DOI: ( /j.clml ) Copyright © 2018 The Authors Terms and Conditions

4 Supplemental Figure 1 Correlation Between EORTC QLQ-C30 Global Health Status Score and 4 Symptom Scales of EORTC QLQ-MY20. Bar Charts Represent Distribution of Each Score (EORTC QLQ-C30 and Each Domain of EORTC QYL-MY20 [Future Perspective, Body Image, Disease Symptoms and Side Effects of Treatment]). Graphs Describe Correlation Between EORTC QLQ-C30 and EORTC QLQ-MY20% and 80% Confidence Intervals (Represented by Lines and Ellipses, Respectively). Numbers Represent Correlation Coefficients Abbreviations: EORTC = European Organization for Research and Treatment of Cancer; QLQ-C30 = Core Quality of Life questionnaire; QLQ-MY20 = Quality of Life Multiple Myeloma module. Clinical Lymphoma, Myeloma and Leukemia  , e13-e28DOI: ( /j.clml ) Copyright © 2018 The Authors Terms and Conditions

Download ppt "Health-Related Quality of Life of Patients With Multiple Myeloma Treated in Routine Clinical Practice in France  Nicolas Despiégel, Chantal Touboul, Alain."

Similar presentations

My Treatment Approach to Hairy Cell Leukemia Rahul R. Naik, MD, Alan Saven, MD Mayo Clinic Proceedings Volume 87, Issue 1, Pages 67-76 (January 2012) DOI:

My Treatment Approach to Hairy Cell Leukemia Rahul R. Naik, MD, Alan Saven, MD Mayo Clinic Proceedings Volume 87, Issue 1, Pages (January 2012) DOI:
Risk of Atrial Fibrillation and Bleeding Diathesis Associated With Ibrutinib Treatment: A Systematic Review and Pooled Analysis of Four Randomized Controlled.

Risk of Atrial Fibrillation and Bleeding Diathesis Associated With Ibrutinib Treatment: A Systematic Review and Pooled Analysis of Four Randomized Controlled.
Incidence and Risk of Cardiac Events in Patients With Previously Treated Multiple Myeloma Versus Matched Patients Without Multiple Myeloma: An Observational,

Incidence and Risk of Cardiac Events in Patients With Previously Treated Multiple Myeloma Versus Matched Patients Without Multiple Myeloma: An Observational,
Large-Cell Transformation of Mycosis Fungoides Occurring at the Site of Previously Treated Cutaneous B-Cell Lymphoma  Jennifer L. Herrmann, Naveed Sami 

Large-Cell Transformation of Mycosis Fungoides Occurring at the Site of Previously Treated Cutaneous B-Cell Lymphoma  Jennifer L. Herrmann, Naveed Sami 
Long-Term Health-Related Quality of Life in Patients With Rectal Cancer After Preoperative Short-Course and Long-Course (Chemo) Radiotherapy  Lisette.

Long-Term Health-Related Quality of Life in Patients With Rectal Cancer After Preoperative Short-Course and Long-Course (Chemo) Radiotherapy  Lisette.
Physiotherapy management of lung cancer

Physiotherapy management of lung cancer
Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management  Jorge E. Cortes, Carlos.

Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management  Jorge E. Cortes, Carlos.
Nathan M. Mollberg, DO, Yalini Vigneswaran, MD, Hedy L

Nathan M. Mollberg, DO, Yalini Vigneswaran, MD, Hedy L
Volume 49, Issue 5, Pages (May 2006)

Volume 49, Issue 5, Pages (May 2006)
Patient-Reported Outcomes Data From REVEAL at the Time of Enrollment (Baseline): A Prospective Observational Study of Patients With Polycythemia Vera.

Patient-Reported Outcomes Data From REVEAL at the Time of Enrollment (Baseline): A Prospective Observational Study of Patients With Polycythemia Vera.
The Effect of Lenalidomide on Health-Related Quality of Life in Patients With Lower- Risk Non-del(5q) Myelodysplastic Syndromes: Results From the MDS-005.

The Effect of Lenalidomide on Health-Related Quality of Life in Patients With Lower- Risk Non-del(5q) Myelodysplastic Syndromes: Results From the MDS-005.
Yuji Nakamoto  Clinical Lymphoma, Myeloma and Leukemia 

Yuji Nakamoto  Clinical Lymphoma, Myeloma and Leukemia 
Effects of Bosutinib Treatment on Renal Function in Patients With Philadelphia Chromosome-Positive Leukemias  Jorge E. Cortes, Carlo Gambacorti-Passerini,

Effects of Bosutinib Treatment on Renal Function in Patients With Philadelphia Chromosome-Positive Leukemias  Jorge E. Cortes, Carlo Gambacorti-Passerini,
Mortality and Vascular Events Among Elderly Patients With Chronic Myeloid Leukemia: A Retrospective Analysis of Linked SEER-Medicare Data  Kathleen Lang,

Mortality and Vascular Events Among Elderly Patients With Chronic Myeloid Leukemia: A Retrospective Analysis of Linked SEER-Medicare Data  Kathleen Lang,
Incidence and Risk of Cardiac Events in Patients With Previously Treated Multiple Myeloma Versus Matched Patients Without Multiple Myeloma: An Observational,

Incidence and Risk of Cardiac Events in Patients With Previously Treated Multiple Myeloma Versus Matched Patients Without Multiple Myeloma: An Observational,
The Epidemiology and Clinical Associations of Stroke in Patients With Acute Myeloid Leukemia: A Review of 10,972 Admissions From the 2012 National Inpatient.

The Epidemiology and Clinical Associations of Stroke in Patients With Acute Myeloid Leukemia: A Review of 10,972 Admissions From the 2012 National Inpatient.
Adaptive statistical iterative reconstruction improves image quality without affecting perfusion CT quantitation in primary colorectal cancer  D. Prezzi,

Adaptive statistical iterative reconstruction improves image quality without affecting perfusion CT quantitation in primary colorectal cancer  D. Prezzi,
Prognostic Nomogram for Overall Survival in Extranodal Natural Killer/T-Cell Lymphoma Patients  Kaiguo Li, Ruyue Wang, Shiting Huang, Xinbin Pan, Hongmin.

Prognostic Nomogram for Overall Survival in Extranodal Natural Killer/T-Cell Lymphoma Patients  Kaiguo Li, Ruyue Wang, Shiting Huang, Xinbin Pan, Hongmin.
Treatment With JAK Inhibitors in Myelofibrosis Patients Nullifies the Prognostic Impact of Unfavorable Cytogenetics  Vincent T. Ma, Philip S. Boonstra,

Treatment With JAK Inhibitors in Myelofibrosis Patients Nullifies the Prognostic Impact of Unfavorable Cytogenetics  Vincent T. Ma, Philip S. Boonstra,
Prolonged Duration of Therapy Is Associated With Improved Survival in Patients Treated for Relapsed/Refractory Multiple Myeloma in Routine Clinical Care.

Prolonged Duration of Therapy Is Associated With Improved Survival in Patients Treated for Relapsed/Refractory Multiple Myeloma in Routine Clinical Care.

Similar presentations

Ads by Google